Europe will legalize marijuana over the next yr or so: Tilray CEO
Irwin Simon, Tilray CEO, joins ‘Tell on the Avenue’ to talk about why cannabis shares proceed to be below strain despite favorable laws, why merchants don’t appear to be seeing…
Green Thumb CEO on what’s next for the cannabis industry
Ben Kovler, Green Thumb Industries CEO, on his company’s earnings and doubtless cannabis laws from the govt. With CNBC’s Courtney Reagan and the Like a flash Money traders, Man Adami,…
Seemingly unusual regulations can also reshape the U.S. cannabis market in 2022
CNBC’s Frank Holland delivers the 2022 Playbook on the cannabis market, because the exchange launches unusual products and Wall Avenue awaits the passage of contemporary rules. For gather admission to…
Cannabis shares rally as U.S. lawmakers mull federal legislation
Are pot shares a secure wager with the SAFE Banking Act gaining momentum? CNBC’s Frank Holland joins ‘Thunder Box’ to interrupt down the sector. For salvage admission to to are…
Tailwinds will in the end come for cannabis stocks: Canaccord Genuity’s Bottomley
Matt Bottomley, Canaccord Genuity analyst, joins ‘Snarl on the Highway’ to chat about Bottomley’s be taught on cannabis sector stocks, what occurs if regulations stumbles and more. For bring collectively…
If cannabis is no longer for sure legalized, firms will continue to consolidate, says Tilray CEO Irwin Simon
Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to focus on about the corporate’s stock and his outlook on marijuana law.
Canada hits third anniversary of cannabis legalization
CNBC’s Frank Holland joins ‘Thunder on the Facet road’ from Toronto where he discusses the three-365 days anniversary of cannabis legalization in Canada. Frank Holland brings in David Klein, Canopy…
ETF Spotlight: Aurora cannabis hit by pandemic-associated restrictions
CNBC’s Morgan Brennan takes a survey at cannabis-focused ETFs and the dip in Aurora shares. For entry to are residing and habitual video from CNBC subscribe to CNBC PRO: »…
Crackdown on Canadian cannabis imports
Florida Score. Matt Gaetz discusses why he thinks imports of Canadian cannabis for U.S. clinical trials is constructing wealth in Canada in desire to the U.S.